Prof Chng Wee Joo

Prof Chng Wee Joo

Prof Chng Wee Joo has been appointed the Executive Director of the Singapore Translational Cancer Consortium since 2019. He is the Vice President (Biomedical Sciences Research) at the National University of Singapore, where he is also a Senior Principal Investigator of the Cancer Science Institute of Singapore. A hematologist by training, he has been a Senior Consultant at the National University Cancer Institute, Singapore for over two decades and concurrently serves as the Group Chief Scientist at the National University Health System.

Prof Chng is a distinguished researcher in the fields of genomics, therapeutics and hematologic malignancies, with extensive experience in clinical practice, administration, and leadership. He has received multiple national and international awards for his highly translational research, which has significantly improved patient outcomes and enabled therapy customization. He is the chair of the Asian Myeloma Network, a member of several prestigious professional groups, such as the International Myeloma Working Group and the American Society of Hematology, and a former president of the Singapore Society of Hematology.